Could routine CMV screening in pregnancy become standard?
NCT ID NCT05699421
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed pilot study tested a universal screening program for cytomegalovirus (CMV) infection in the first trimester of pregnancy. Over 3,300 pregnant women in Barcelona were screened to measure how common CMV infection is and how often it leads to fetal or newborn problems. The goal was to see if routine screening is feasible and useful for guiding care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could support routine CMV screening in early pregnancy to identify infections and guide monitoring.
- What could go wrong
- This is a pilot study, not a treatment trial. It only measures infection rates and outcomes, so it won't directly prevent or cure CMV.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCREENING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
ASSIR Metropolitana Nord
Badalona, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a $5 gift card or $100 drawing get more people to answer health surveys?
- New tool could help doctors identify patients needing end-of-life care earlier
- Can a pre-surgery mist prevent waking confusion after sinus surgery?
- Rural china study aims to catch heart failure early in seniors with irregular heartbeat
- Nepal study tests whether fighting stigma gets more women screened for cervical cancer
- New school program aims to catch teen mental health issues early